Skip to content

Study · Randomized controlled trial · n = 33 · 2020

1 result

Unchanged food approach-avoidance behaviour of healthy men after oxytocin administration.

Melkonyan A, Liu L, Brown EC, Meyer W, Madipakkam AR, Ringelmann L, Lange F, Schmid SM, Münte TF, Park SQ

Journal of neuroendocrinology14 Dec 2020Cited by 6 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In healthy men, intranasal oxytocin did not significantly change motivational behaviour towards food in an approach-avoidance task versus placebo.

    In plain wordsIn healthy men, oxytocin nasal spray did not change how strongly they were drawn to or away from food, compared with placebo.

    Peptide
    Oxytocin
    Outcome
    No significant changeMotivational approach-avoidance behaviour towards food
    Study

    n = 33

    Comparator
    Placebo
    Outcome group
    Appetite and food intake · Metabolic and weight
    Studied dose
    Dose not stated · intranasalAs given in this study (human).

    Source sentences

    Summary
    Most importantly, we did not observe any significant effects of oxytocin compared to placebo in motivational behaviour towards food.
    2 context sentences
    Summary · context
    In the present study, we used a food-based approach-avoidance task (AAT) in a randomised, placebo-controlled, double-blind, cross-over design to compare intranasal oxytocin with a placebo.
    Summary · context
    Thirty-three healthy male participants (age = 25.12 ± 3.51 years; body mass index = 24.25 ± 2.48 kg/m2 ) completed the two-session study, one with placebo and the other with oxytocin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:48 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.